Related Experiment Video
Updated: Jan 27, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Combined MAPK Pathway and HDAC Inhibition Breaks Melanoma
David B Lombard1,2, Tomasz Cierpicki1, Jolanta Grembecka1
1Department of Pathology, University of Michigan, Ann Arbor, Michigan. jolantag@umich.edu davidlom@med.umich.edu tomaszc@umich.edu.
Abstract:
In this issue, Maertens and colleagues demonstrate that HDAC3 inhibition potentiates the effects of MAPK pathway inhibitors in melanoma, including difficult-to-treat NRAS- and NF1-driven tumors, with MGMT expression serving as a biomarker for responsiveness to the BRAF/MEK/HDAC inhibitor combination. Mechanistically, this triple cocktail suppresses expression of genes involved in DNA repair, leading to enhanced killing of melanoma cells.See related article by Maertens et al., p. 526.
Related Concept Videos
Feedback Inhibition
MAPK Signaling Cascades
Fixing Double-strand Breaks
Fixing Double-strand Breaks
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Enzyme Inhibition

